Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Infection|January 18, 2024
Donor respiratory multidrug-resistant bacteria and lung transplantation outcomesRayid Abdulqawi, Rana Ahmed Saleh, Reem Mahmoud Alameer, et al.
Advances in Therapy|March 12, 2026
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia GravisSaiju Jacob, Mahmoud Hashim, Brian Hutton, et al.
British Journal of Haematology|February 19, 2020
Comparison of efficacy from two different dosing regimens of bortezomib: an exposure-response analysisDolly A Parasrampuria, Jianming He, Liping Zhang, et al.
Advances in Therapy|July 3, 2024
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate CancerMaria De Santis, Sara Martínez Breijo, Paul Robinson, et al.
Blood Advances|December 7, 2020
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myelomaNikhil C Munshi, Herve Avet-Loiseau, Kenneth C Anderson, et al.
Advances in Therapy|June 12, 2026
Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-AnalysisAndrew J Cutler, Anaïs Lemyre, Qiaoyi Zhang, et al.
Advances in Therapy|November 12, 2024
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023Ataru Igarashi, Shiro Tanaka, Raf De Moor, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2024
A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best PracticesShiro Tanaka, Ataru Igarashi, Raf De Moor, et al.
Immunotherapy|November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparisonPhilippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Pageof 4